Link Between Immune System Suppression And Blood Vessel Formation In Tumors
7/14/2011

Targeted therapies that are designed to suppress the formation of new blood vessels in tumors, such as Avastin (bevacizumab), have slowed cancer growth in some patients. However, they have not produced the dramatic responses researchers initially thought they might. Now, research from the Perelman School of Medicine at the University of Pennsylvania might help to explain the modest responses...

Novel Compound Selectively Kills Cancer Cells By Blocking Their Response To Oxidative Stress
7/14/2011

A cancer cell may seem out of control, growing wildly and breaking all the rules of orderly cell life and death. But amid the seeming chaos there is a balance between a cancer cell's revved-up metabolism and skyrocketing levels of cellular stress...

42% Of People Will Get Cancer Says Leading UK Health Charity
7/14/2011

42% of people in the UK will get cancer, says a leading UK health charity that also concludes while people are living longer with cancer, they are not necessarily living well, and this will place a massive burden on the NHS...

23 Patients With Organ Confined Low Risk Prostate Cancer Have Been Treated In Clinical Trials Using The ExAblate(R) Non-Invasive Prostate System
7/14/2011

InSightec Ltd., the global leader in MR-guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate® system for treating uterine fibroids, announced today that 23 patients with organ confined low risk prostate cancer have already been treated with its ExAblate® system in clinical trials, showing promising initial results...

Computation Of Gene Migration Helps Predict Movement Of Disease
7/14/2011

Until recently, migration patterns, such as those adopted by birds all across the Amazonian rainforest, have not been thought to play an important role in the spreading of beneficial genes through a population...

Short-Term Hormone Therapy Plus Radiation Therapy Increases Survival For Men With Early-Stage Prostate Cancer
7/14/2011

Short-term hormone therapy (androgen deprivation therapy: ADT) given in combination with radiation therapy for men with early-stage prostate cancer increases their chance of living longer and not dying from the disease, compared with that of those who receive the same radiation therapy alone, according to a Radiation Therapy Oncology Group (RTOG) study published in the July 14 ...

Lycopene May Help Prevent Prostate Cancer In African Americans
7/14/2011

Lycopene, a red pigment that gives tomatoes and certain other fruits and vegetables their color, could help prevent prostate cancer, especially in African American men, according to new research at the University of Illinois at Chicago...

Stem Cell Treatment May Restore Cognitive Function In Patients With Brain Cancer
7/14/2011

Stem cell therapy may restore cognition in patients with brain cancer who experience functional learning and memory loss often associated with radiation treatment, according to a laboratory study published in Cancer Research, a journal of the American Association for Cancer Research. Charles Limoli, Ph.D...

Almost All Patients With High Grade Bladder Cancer Do Not Receive Recommended Care
7/13/2011

An alarming revelation was made by scientists at the UCLA's Jonsson Comprehensive Cancer Center regarding high-grade, non-invasive bladder cancer patients. These patients are not receiving the recommended standard of care to prevent recurrences...

PSA Test For Men Could Get A Second Life For Breast Cancer In Women
7/13/2011

The widely known PSA blood test for prostate cancer in men may get a second life as a much-needed new test for breast cancer, the most common form of cancer in women worldwide, scientists are reporting in a new study in the ACS journal Analytical Chemistry...